Results 21 to 30 of about 60,915 (280)

Prevalence of Hepatitis B and Hepatitis C in patients undergoing hemodialysis at a teaching hospital in Uttarakhand

Journal of Family Medicine and Primary Care, 2022
Introduction: Hemodialysis (HD) requires blood exposure to infectious materials through the extracorporeal circulation for a prolonged period, and exposure to risk factors for nosocomial infections is always there.
Dimple Raina, Neha Rawat, Ajay K Pandita
doaj   +1 more source

The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance

, 2023
Off-treatment HBsAg reversion occurs in a considerable number of chronic hepatitis B(CHB) patients after IFN(interferon)-induced HBsAg clearance. HBV vaccination protects the general population against HBV infection.
Shaowen Jiang, Simin Guo, Hui Wang, Yan Huang, Cong Qian, Haiguang Xin, Wei Cai, Zhenglan Zhang, Minghao Cai, Qing Guo, Ziqiang Li, Qing Xie, Huijuan Zhou, Jiexiao Wang   +13 more
core   +2 more sources

Hepatitis B elimination in children of Slovenian origin born in Slovenia after the introduction of preventive strategies: The results of a national study

Slovenian Journal of Public Health, 2022
In Slovenia national strategies to prevent hepatitis B virus (HBV) infection in children were introduced in the mid-nineties. The aim of the present study was to analyze the epidemiological characteristics of chronic hepatitis B infection in children in ...
Kmet Nina Grasselli, Poljak Mario, Zakotnik Breda, Matičič Mojca   +3 more
doaj   +1 more source

Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania. [PDF]

, 2013
\ud \ud Co-infection with hepatitis B virus (HBV) is highly prevalent in people living with HIV in Sub-Saharan Africa. Screening for HBV surface antigen (HBsAg) before initiation of combination antiretroviral therapy (cART) is recommended. However, it is
Emilio Letang, Mwaigomole, Geoffrey, Battegay, Manuel, Lars Henning, Abdul, Omary, Marcel Tanner, Hatz, Christoph, Ngwale, Ramadhani, Franzeck Fabian C., Henning, Lars, Geoffrey Mwaigomole, Ramadhani Ngwale, Marian Hamisi, Tanner, Marcel, Omary Abdul, Ngwale Ramadhani, Hamisi, Marian, Mwaigomole Geoffrey, Bernadeta Msongole, Henning Lars, Tanner Marcel, Franzeck, Fabian C., Manuel Battegay, Msongole Bernadeta, Fabian C Franzeck, Fabian C. Franzeck, Msongole, Bernadeta, Letang, Emilio, Hamisi Marian, Hatz Christoph, Letang Emilio, Battegay Manuel, Christoph Hatz, Franzeck, Fabian C, Abdul Omary   +34 more
core   +1 more source

Seroprevalence of Hepatitis B Virus in HIV Tested Positive Patients Accessing Treatment in Specialist Hospital Jimeta

Dr. Sulaiman Al Habib Medical Journal, 2021
Background: Human Immunodeficiency Virus (HIV) positive patients are likely to be at risk of other infectious pathogens such as Hepatitis B Virus (HBV).
Mohammed Bashir, Halima Ibrahim, Halima Isa   +2 more
doaj   +1 more source

HBsAg-specific IgG1 and IgG2a Ab titers.

, 2018
HBsAg-specific IgG1 and IgG2a Ab titers.
Blair A. Harrison (6041411), Renu Dudani (6041408), Lakshmi Krishnan (183256), Gerard Agbayani (6041414), Lise Deschatelets (6041405), Michael J. McCluskie (465262), Bassel Akache (30143), Dean Williams (392183), Yimei Jia (6041402), Mohammad P. Jamshidi (6041417), Felicity C. Stark (183247)   +10 more
core   +1 more source

Performance of HBsAg point-of-care tests for detection of diagnostic escape-variants in clinical samples [PDF]

, 2015
BACKGROUND Hepatitis B viruses (HBV) harboring mutations in the a-determinant of the Hepatitis B surface antigen (HBsAg) are associated with reduced reactivity of HBsAg assays.
Hirzel, Cédric, Zürcher, Samuel, Pfister, Stefan, Wandeler, Gilles, Gorgievski, Meri   +4 more
core   +1 more source

Evaluation of CLIA plus NAT for detecting HBsAg single-ELISA-reactive samples of blood donors

Zhongguo shuxue zazhi, 2022
Objective To study the detection performance of HBsAg single-ELISA-reactive samples of blood donors. Methods Two kinds of ELISA reagents from different manufacturers (named as reagents A and B) were used for HBsAg screening.
Jiayi SUN, Xiuwen NI, Zhen LUO, Chengkuan HUANG, Jiayan TU, Xiaoyuan LI, Wen GAO, Rui XU   +7 more
doaj   +1 more source

Hepatitis B Surface Antigen Loss and Improved Clinical Outcomes in US Individuals With Chronic Hepatitis B Virus Infection. [PDF]

J Viral Hepat
ABSTRACT Hepatitis B surface antigen (HBsAg) loss is associated with improved clinical outcomes in patients with chronic hepatitis B virus (HBV) infection based on studies predominantly in Asian populations. We assessed real‐world associations between HBsAg loss and long‐term clinical outcomes in a diverse US population with chronic HBV infection. This
Drysdale M, Chang R, Wang S, Coutinho A, Gielen V, Man T, Song R, Duh MS, Khalili M, Theodore D.   +9 more
europepmc   +2 more sources

Correlation between the HBsAg level and the peripheral blood lymphocytes profile in chronic hepatitis B patients from Malaysia [PDF]

, 2016
Background: In recent times, the hepatitis B virus surface antigen (HBsAg) level, a cheaper marker compared to the molecular method, has been used not only for indicating active hepatitis B virus (HBV) infection, but also for predicting the clinical and ...
Mustafa Mahmoud, Mohammed Imad Al-Deen, Hadi, Qabas Neamah, Hui, Yee Chee, Hadi, Qabas Naemah, Jaafar, Khairul Azhar, Mustafa, Mohammed Imad Al-Deen, Jaafar, KhairulAzhar   +6 more
core   +1 more source